HARKE Pharma GmbH
HARKE Pharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1992, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a commitment to innovation and quality, HARKE Pharma offers a diverse portfolio that caters to both generic and specialty markets. Their unique approach to product development and stringent quality control measures have earned them a strong market position and recognition for excellence in the industry. HARKE Pharma continues to expand its global footprint, driven by a dedication to improving healthcare outcomes and meeting the evolving needs of patients worldwide.
DitchCarbon Score
How does HARKE Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HARKE Pharma GmbH's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HARKE Pharma GmbH's reported carbon emissions
HARKE Pharma GmbH, headquartered in India, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. In the absence of detailed emissions data, it is important to note that HARKE Pharma has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. This indicates a potential area for growth in their sustainability strategy, particularly in setting measurable goals for carbon footprint reduction. As the pharmaceutical industry increasingly prioritises climate action, HARKE Pharma may benefit from establishing clear emissions reduction initiatives and aligning with industry standards to enhance their environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HARKE Pharma GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
